Latest drugs in the treatment of cancer

New-drugs-in-advanced-cancer-treatment
Recent advancements in cancer treatment include immunotherapies like checkpoint inhibitors and CAR-T cell therapies, which harness the immune system to target cancer cells. Precision medicine, using genetic profiling to match treatments to specific mutations, has also gained prominence. Additionally, targeted therapies and combination treatments show promise in improving outcomes for cancer patients.

Share This Post

July 2021: Check out the latest drugs in the treatment of cancer. Every year, after examining the trials and other important factors, the USFDA approves drugs, and thus cancer patients can now believe that a cure is very near.

In recent years, a lot has happened to change the way the disease is and will be handled. As a consequence, people with cancer and their clinicians have more choices to choose from and more on the way.

Check : Cost of cancer treatment in India

The ability of your cells to evade your immune system is one factor that makes fighting cancer challenging. Your body just doesn’t see them as threats, or it just can’t work to fight them hard enough.

But these cells are “marked” by certain modern immunotherapy drugs, so they are easier to find. These medications can also make the defenses of your body stronger so that they can attack tumors.

This type of treatment is already effective against some types of cancer. Many more medications are in the works.

A type of gene treatment called CAR T-cell therapy has been approved by the FDA. It uses some of your own immune cells to treat your cancer, called T cells. By inserting fresh genes, doctors take the cells out of your blood and change them so they can identify and destroy cancer cells faster.

Check : Cost of CAR T-cell therapy for acute lymphoblastic leukemia (ALL) in Israel

The drug called tisagenlecleucel (Kymriah) is currently approved for the treatment of B-cell acute lymphoblastic leukemia in children and young adults up to 25 years of age who have not progressed with other therapies. But for adults and other forms of cancer, scientists are working on a variant of CAR T-cell therapy.

Tisagenleucel and axicabtagene (Yescarta) are both approved to treat some types of adult B-cell lymphoma that other treatments have not been able to help.

Check : Cost of CAR T-cell therapy in China

A new therapy called brexucabtagene autoleucel (Tecartus) has recently been approved by the FDA in patients with mantle cell lymphoma who have not progressed with other therapies or have come back after treatment.

Cancer is still an unresolved mystery, and scientists, physicians, and corporations around the world are still seeking to find the best possible cure to this deadly disease. As of now, chemotherapy is one of the most effective tools in the hands of cancer specialists in India and around the world, who, if diagnosed early, can combat the disease to a large extent. We’ve seen a lot of new medications come out in the past few years to combat cancer cells. This also requires targeted therapy that aims to attack the cells specifically, allowing the normal cells to experience less damage. USFDA also approved its first approval for gene alteration therapy this year in 2017, altering patients’ own t cells to make it more effective against cancer fighting.

In 2017, USFDA gave approval for some of the drugs which they believe will make a major difference in the treatment of cancer. They are:

  1. Bavencio (Avelumab) – Bladder cancer
  2. Kisqali (Ribociclib) – Breast cancer
  3. Nerlynx (Neratinib) – Breast cancer
  4. Rydapt (Midostaurin) – Leukaemia
  5. Besponsa (Inotuzumab Ozagamicin) – Leukaemia
  6. Kymriah (Tisagenlecleucel) – Leukaemia
  7. Tafinlar (Dabrafanib) – Lung cancer
  8. Mekinist (Trametinib) – Lung cancer
  9. Opdivo (Livolumab) – Liver cancer
  10. Yescarta (Axicabtagene ciloleucel) – Lymphoma
  11. Calquence (Acalabrutunib) – Lymphoma
  12. Bavencio (Avelumab) – Merkel cell carcinoma
  13. Zejula (Niraparib) – Ovarian cancer
  14. Keytruda (Pembrolizumab) – Stomach cancer
+ posts

Dr. Nishant Mittal is a highly accomplished researcher with over 13 years of experience in the fields of cardiovascular biology and cancer research. His career is marked by significant contributions to stem cell biology, developmental biology, and innovative research techniques.

Research Highlights

Dr. Mittal's research has focused on several key areas:

1) Cardiovascular Development and Regeneration: He studied coronary vessel development and regeneration using zebrafish models1.

2) Cancer Biology: At Dartmouth College, he developed zebrafish models for studying tumor heterogeneity and clonal evolution in pancreatic cancer.
3) Developmental Biology: His doctoral work at Keio University involved identifying and characterizing medaka fish mutants with cardiovascular defects.

4) Stem Cell Research: He investigated the effects of folic acid on mouse embryonic stem cells and worked on cryopreservation techniques for hematopoietic stem cells.

Publications and Presentations

Dr. Mittal has authored several peer-reviewed publications in reputable journals such as Scientific Reports, Cardiovascular Research, and Disease Models & Mechanisms1. He has also presented his research at numerous international conferences, including the Stanford-Weill Cornell Cardiovascular Research Symposium and the Weinstein Cardiovascular Development Conference.

In summary, Dr. Nishant Mittal is a dedicated and accomplished researcher with a strong track record in cardiovascular and cancer biology, demonstrating expertise in various model systems and a commitment to advancing scientific knowledge through innovative research approaches.

Subscribe To Our Newsletter

Get updates and never miss a blog from Cancerfax

More To Explore

Advancements in adoptive CAR immune cell immunotherapy synergistically combined with multimodal approaches for tumor treatment
CAR T-Cell therapy

Advancements in adoptive CAR immune cell immunotherapy synergistically combined with multimodal approaches for tumor treatment

CAR T cell therapy has transformed cancer treatment, especially in hematological malignancies. Treatment of solid tumors remains challenging due to their immunosuppressive tumor microenvironment. Combination with chemotherapy, immune checkpoint inhibitors, oncolytic viruses, and improved genetic engineering holds promise. Multimodal approaches enhance immune cell infiltration and persistence, raising efficacy. Evolving personalized methods will be instrumental in overcoming solid tumor resistance and improving patient outcomes.

How to prevent infections in patients receiving CD19-targeted chimeric antigen receptor T cells for B-cell malignancies
CAR T-Cell therapy

How to prevent infections in patients receiving CD19-targeted chimeric antigen receptor T cells for B-cell malignancies?

CAR T-cell therapy revolutionized cancer therapy, offering incredible success in the management of B-cell malignancies, but it is associated with severe infection risks secondary to immunosuppression. Preventive measures are pre-infusion screening, vaccination, and antimicrobial prophylaxis. Post-infusion, close surveillance for infection and cytokine release syndrome management are key. Long-term care includes the treatment of hypogammaglobulinemia, revaccination, and patient education. The approach ensures improved outcomes and reduces infection-related complications in patients receiving CD19-targeted CAR T-cell therapy.

Need help? Our team is ready to assist you.

We wish a speedy recovery of your dear and near one.

Start chat
We Are Online! Chat With Us!
Scan the code
Hello,

CancerFax is the most trusted online platform dedicated to connecting individuals facing advanced-stage cancer with groundbreaking cell therapies.

Send your medical reports and get a free analysis.

🌟 Join us in the fight against cancer! 🌟

Привет,

CancerFax — это самая надежная онлайн-платформа, призванная предоставить людям, столкнувшимся с раком на поздних стадиях, доступ к революционным клеточным методам лечения.

Отправьте свои медицинские заключения и получите бесплатный анализ.

🌟 Присоединяйтесь к нам в борьбе с раком! 🌟